Langwirkende Wachstumshormondosierformen

Details

Veröffentlichungs-Nr.

EP4732848

Anmeldetag

20. November 2015

Veröffentlichung

29. April 2026

Rechtsraum

EP

IPC

A61K47/60(ASCENDIS PHARMA AS et al.)

Abstract

The present invention relates a pharmaceutical formulation comprising a long-acting growth hormone for use in a method of treating growth hormone deficiency, wherein the long-acting growth hormone formulation is administered to a patient in a bracketed dosage regimen, to a multitude of unit dosage forms comprising a long-acting growth hormone formulation, wherein the unit dosage forms comprise increasing amounts of growth hormone equivalents and wherein the amount of growth hormone equivalents increases by at least 10% between one unit dosage form and the next higher dosage form; their use in a method of treating growth hormone deficiency and method of treating growth hormone deficiency in a bracketed dosing regimen.

Anmelder

Firma

ASCENDIS PHARMA ENDOCRINOLOGY DIVISION A/S

Land

🇩🇰 Dänemark

Fachgebiete